Skip to main content

Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance

Medically reviewed by Carmen Pope, BPharm. Last updated on March 7, 2025.

By I. Edwards HealthDay Reporter

FRIDAY, March 7, 2025 -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%. The new price -- $499 per month -- takes effect immediately. It had been $650 a month.

The discount applies to all dose levels of the medication, NBC News reported.

The lower price is available to both uninsured patients and people whose insurance does not cover weight-loss drugs, the company also said.

Last week, Eli Lilly, the maker of Zepbound, also cut prices for its starter dose to $349 per month.

Larger doses will now cost $499 per month through the company's self-pay program.

People using these GLP-1 meds start with smaller doses and gradually increase to higher amounts over time.

The price cuts come as supply issues ease. Both medications have recently been removed from the U.S. Food and Drug Administration's shortage list, allowing the companies to meet growing demand.

As a result, compounding pharmacies, which were allowed to make off-brand versions during the shortage, will need to wind down production.

Both Wegovy and Zepbound belong to a class of drugs that have been shown to help people lose weight by reducing appetite and increasing the feelings of fullness.

Sources

  • NBC News, March 5, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted March 2025

Read this next

More Than 460 CDC Workers Reinstated After Layoffs

FRIDAY, June 13, 2025 — More than 460 laid-off employees at the U.S. Centers for Disease Control and Prevention (CDC) are being rehired, officials said June 11. The...

'Forever Chemicals' Linked To Elevated Childhood Blood Pressure

FRIDAY, June 13, 2025 — Kids exposed to PFAS “forever chemicals” before birth have an increased risk of high blood pressure in childhood, particularly during...

CT Scans Outperform DNA Stool Tests In Colon Cancer Screening, Study Says

FRIDAY, June 13, 2025 —  CT scans might be able to prevent more colon cancers than stool DNA tests, a new study says. CT colonography performed every three to five...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.